Literature DB >> 2752176

Human monoclonal autoantibodies to characterize platelet antigens in immune-mediated thrombocytopenia.

D J Nugent1.   

Abstract

Idiopathic thrombocytopenic purpura is characterized by antiplatelet antibodies which mediate the rapid destruction of these cells by the reticuloendothelial cell system. Low serum titers of autoantibodies and the polyclonal nature of human serum make it difficult to identify platelet target antigens with plasma antibodies. To circumvent these problems, we have utilized the techniques of EBV transformation and somatic cell hybridization in order to isolate human monoclonal antibodies from patients with ITP. In this paper we describe the use of human monoclonal autoantibodies to characterize an activation specific antigen on GPIIIa and an autoantigen on the GPIb complex. Ultimately, we hope to determine whether these autoantibodies emerge from a pool of naturally occurring antibodies to activation or senescence antigens, or are triggered by environmental agents such as bacteria or virus, which are comprised of antigens similar to those found on the platelet membrane.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752176     DOI: 10.1007/bf00320249

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  20 in total

1.  Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies.

Authors:  R G Andrews; B Torok-Storb; I D Bernstein
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

2.  Possible mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  P Imbach; T W Jungi
Journal:  Blut       Date:  1983-03

3.  Specificity of autoantibodies in autoimmune thrombocytopenia.

Authors:  E F van Leeuwen; J T van der Ven; C P Engelfriet; A E von dem Borne
Journal:  Blood       Date:  1982-01       Impact factor: 22.113

4.  Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura.

Authors:  V L Woods; Y Kurata; R R Montgomery; P Tani; D Mason; E H Oh; R McMillan
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

5.  Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP.

Authors:  R McMillan; P Tani; F Millard; P Berchtold; L Renshaw; V L Woods
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

6.  A naturally occurring, warm-reactive macroglobulin specific for papain-treated human platelets: preliminary characterization.

Authors:  J C Gill; P Carlson; T J Kunicki; R H Aster
Journal:  Am J Hematol       Date:  1986-02       Impact factor: 10.047

7.  Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura.

Authors:  J B Bussel; R P Kimberly; R D Inman; I Schulman; C Cunningham-Rundles; N Cheung; E M Smithwick; J O'Malley; S Barandun; M W Hilgartner
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

8.  Pseudothrombocytopenia: a cold autoantibody against platelet glycoprotein GP IIb.

Authors:  H H van Vliet; M C Kappers-Klunne; J Abels
Journal:  Br J Haematol       Date:  1986-03       Impact factor: 6.998

9.  Polyspecific natural antibodies and autoantibodies secreted by human lymphocytes immortalized with Epstein-Barr virus.

Authors:  J M Seigneurin; B Guilbert; M J Bourgeat; S Avrameas
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

10.  The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis.

Authors:  T J Kunicki; D Pidard; J P Rosa; A T Nurden
Journal:  Blood       Date:  1981-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.